Pages that link to "Q40700314"
Jump to navigation
Jump to search
The following pages link to Genetic and environmental contributions to platelet aggregation: the Framingham heart study. (Q40700314):
Displaying 50 items.
- Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study (Q21261432) (← links)
- VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA (Q24609475) (← links)
- Platelet function and ageing (Q26749231) (← links)
- Relationship of arachidonic acid concentration to cyclooxygenase-dependent human platelet aggregation (Q28165301) (← links)
- Cyclooxygenase-1 haplotype modulates platelet response to aspirin (Q28191434) (← links)
- Common variations in platelet glycoproteins: pharmacogenomic implications (Q28191774) (← links)
- Primary prevention of coronary heart disease with aspirin (Q28192984) (← links)
- Aspirin resistance (Q28195157) (← links)
- Sex difference in the antiplatelet effect of aspirin in patients with stroke (Q28196479) (← links)
- Clinical implications of aspirin resistance (Q28221576) (← links)
- Discovery of novel GPVI receptor antagonists by structure-based repurposing (Q28540147) (← links)
- Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. (Q30500885) (← links)
- Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c (Q30558959) (← links)
- Platelet adhesion onto immobilized fibrinogen under arterial and venous in-vitro flow conditions does not significantly differ between men and women (Q33282914) (← links)
- Inherited dysfunctional nitric oxide signaling and the pathobiology of atherothrombotic disease (Q33642069) (← links)
- Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group (Q33863833) (← links)
- Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development (Q33988457) (← links)
- Implementing genotype-guided antithrombotic therapy (Q33990428) (← links)
- Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study (Q34023032) (← links)
- The genetics of normal platelet reactivity (Q34282183) (← links)
- Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function (Q34374101) (← links)
- Genetic determinants of on-aspirin platelet reactivity: focus on the influence of PEAR1. (Q34435298) (← links)
- Genetics of the Framingham Heart Study population (Q34458072) (← links)
- Cellular phenotypes and the genetics of hypertension (Q34492797) (← links)
- Prakriti (Ayurvedic concept of constitution) and variations in platelet aggregation (Q34507730) (← links)
- Association of single nucleotide polymorphisms on chromosome 9p21.3 with platelet reactivity: a potential mechanism for increased vascular disease (Q34543464) (← links)
- The complex transcriptional landscape of the anucleate human platelet (Q34549628) (← links)
- Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race (Q34580117) (← links)
- Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists (Q34674600) (← links)
- Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance (Q34771381) (← links)
- Single nucleotide polymorphism network: a combinatorial paradigm for risk prediction (Q34989717) (← links)
- Antithrombotic therapy in patients with acute coronary syndrome in the intermountain heart collaborative study (Q34997324) (← links)
- Aging of the nitric oxide system: are we as old as our NO? (Q35026305) (← links)
- Clinicians' guide to statistics for medical practice and research: part I (Q35063619) (← links)
- The genetics of common variation affecting platelet development, function and pharmaceutical targeting (Q35149898) (← links)
- Novel family-based approaches to genetic risk in thrombosis (Q35181584) (← links)
- Nitric oxide and its relationship to thrombotic disorders (Q35181680) (← links)
- Polymorphism in the protease-activated receptor-4 gene region associates with platelet activation and perioperative myocardial injury (Q35212303) (← links)
- Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression (Q35230231) (← links)
- Phenotyping patient-derived cells for translational studies in cardiovascular disease (Q35686793) (← links)
- Genetic association analysis highlights new loci that modulate hematological trait variation in Caucasians and African Americans. (Q36234313) (← links)
- Investigating the genetic determinants of cardiovascular disease using candidate genes and meta-analysis of association studies (Q36454338) (← links)
- P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease (Q36536498) (← links)
- Effect of Frailty and Age on Platelet Aggregation and Response to Aspirin in Older Patients with Atrial Fibrillation: A Pilot Study (Q36999944) (← links)
- Aspirin resistance in atherosclerosis (Q37140091) (← links)
- Genetic dissection of platelet function in health and disease using systems biology (Q37156517) (← links)
- A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability (Q37336145) (← links)
- Genomics: risk and outcomes in cardiac surgery (Q37347806) (← links)
- Clopidogrel resistance: pharmacokinetic or pharmacogenetic? (Q37402214) (← links)
- CVDHD: a cardiovascular disease herbal database for drug discovery and network pharmacology (Q37426159) (← links)